Drugs / 14C-ETX2514
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04018950 | Jun → Jul 2019 | Acinetobacter infectious disease | Entasis Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 14C-ETX2514 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04018950 ↗ |
| Route | Intravenous | “intravenous infusion” NCT04018950 ↗ |